Stem Cell Therapy for Rod and Cone Dystrophy in South Africa

Providing patients with the most effective treatments, remedies, and medications is crucial. The eyes play an essential role in our daily lives and cognitive functions, emphasizing the importance of preserving health. While curing Rod dystrophy may present challenges or be impossible, continuous efforts in this regard remain essential. It remains the duty of healthcare providers to exhaust all avenues to either restore vision or explore treatments aimed at enhancing visual capabilities.

Dystrophy originates from genetic mutations that affect the cone photoreceptor cells within the retina. Ongoing research has identified roughly 35 genes responsible for these mutations. These alterations lead to the gradual degeneration of these cells, resulting in a progressive loss of vision. These conditions collectively impact an estimated 1 in 20,000 to 100,000 individuals worldwide. Eye injuries are broadly categorized into minor and major types. Minor injuries may occur due to exposure to dust, soap, smoke, etc., while major injuries typically result from accidents involving the eye.

Rod and cone stem cell treatment:

Stem Cell Therapy for Rod and Cone Dystrophy offers advanced facilities providing innovative treatments for Rod and Cone conditions, eliminating the need for seeking treatment abroad. These facilities prioritize cutting-edge technology and maintain stringent hygiene standards to ensure optimal patient care.

Rod and Cone diseases progressively impact vision, posing a risk of vision loss without timely intervention. Definitive treatments for these genetic conditions are presently limited due to their direct link to genes. However, Stem Cell Treatment emerges as a promising approach, aiming to regenerate affected photoreceptor cells, arresting further deterioration, and promoting long-term eye health.

The approach involves Mesenchymal stem cells administered through a safe and effective route known as “Retro-bulbar” injections, maximizing the regeneration of flawed or damaged retinal photoreceptor cells. Stem Cell Therapy in South Africa specializes not only in Rod and Cone dystrophies but also in treating conditions like Stargardt’s/Macular Dystrophy, diabetic retinopathy, and macular degeneration, among others.

Diabetic retinopathy, a complication linked to high blood sugar levels, damages blood vessels within the retina. The Eye Stem Cell center addresses this issue, emphasizing the importance of managing blood sugar levels to mitigate complications. By intervening at the cellular level, the Centre aims to prevent or alleviate the adverse effects of diabetic retinopathy.

Treatment protocols focus on regenerating photoreceptor cells, providing personalized care tailored to the patient’s health status. Stem Cell Therapy harnesses the body’s regenerative capacity to restore vision and maintain ocular health over an extended period. Through a comprehensive approach and specialized protocols, the Centre aims to combat various retinal conditions, offering hope and an improved quality of life for patients with vision-related ailments.

Stem Cell Treatment holds promise in addressing these conditions by restoring vision through regenerating damaged photoreceptor cells linked with Rod and Cone diseases. The treatment aims to halt further degradation of these cells, contributing to ocular health restoration and sustained eye regeneration. We provide our services through some medical devices such as bone marrow aspiration concentrate (BMAC) kit, platelet-rich plasma (PRP) kit, and Stem Cell Therapy in Africa services (isolated from bone marrow, placenta and adipose) for research/clinical trial purposes only.